Login to Your Account

Antibody Deal Includes $85M Up Front

Regeneron Signs Sanofi To Potential $1B Collaboration

By Donna Young

Friday, November 30, 2007
Regeneron Pharmaceuticals Inc. and Sanofi-Aventis are collaborating to discover, develop and commercialize human therapeutic antibodies in a cash and stock deal potentially worth $1 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription